Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
Login Archives Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
    ×
  • Subscribe
Enter stock ticker or keyword
×
Join 100,000+ Like-Minded Investors Today
Twitter
XBI

S&P Biotech SPDR

Stocks

Winter Is Coming: Here’s How to Prepare

August 23, 2022 by Garrett Baldwin

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Garrett Baldwin gives a sneak peek at what's coming for the markets as we draw closer to winter.

Read more...

Stocks

How to Profit in a $29 Billion “New Biotech” Sector

May 14, 2021 by Shah Gilani

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Back in the late 1960s and early 1970s, psychedelics drugs like LSD were still legal and could be researched.

But in 1968 when the federal government criminalized them, a lot of promising research stopped.

Now the spotlight is back on these drugs and the success they’ve shown in clinical trials for treating a range of mental health conditions.

This is not only great news for people suffering from these conditions, but also for savvy investors who’ll get in on the ground floor of a market that could be worth more than $29 billion by the end of the decade.

Here’s Shah with all the details….

Read more...

Cannabis

There's Still Some Time to Move on This Must-Own Biotech

February 24, 2021 by Don Yocham

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Some market-leading biotech firms are working hard right now developing drugs derived from cannabis' many beneficial compounds.

And there's one innovative company that puts you right in the middle of the sector's market-crushing gains.

Plus, there's still some time left to get in and grab the profits….

Read more...

Biotechnology

Instead of Chasing Every New Vaccine "Breakthrough," Trade the Whole Sector

October 31, 2020 by Andrew Keene

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Not every biotech company is doing well in the search for an effective COVID-19 vaccine or treatment.

And the latest firm to struggle is Eli Lilly, whose antibody clinical trial was paused due to failure to show any real results.

So today, Andrew's going to show you a much more profitable move to make instead of chasing every vaccine "breakthrough" news…

Read more...

Dow Jones

The Dow Jones Today Will Lose Hundreds of Points as China Raises Tariffs

May 13, 2019 by Garrett Baldwin

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The Dow Jones today will plummet as China plans its own tariff hike on $60 billion of U.S. goods starting June 1.

This is the latest intensification of a trade war between the countries.

Read more here...

Biotechnology

Let's Buy the Real Breakout in the Soaring Tech Sector

June 7, 2018 by Chris Johnson

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The tech sector has been having a field day lately, and our Chris Johnson is back with his latest "Best in Breed" focus: biotech.

Find out how the numbers don't lie when it comes to this sector...

Stocks

The 3 Best Biotech Stocks to Buy for 2018

February 20, 2018 by Money Morning News Team

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Investors looking for profits in the healthcare sector had a difficult time in 2017 if they weren't in biotech. The Health Care SPDR ETF only gained 13.15% last year, while the S&P 500 climbed 22.5% over the same time period.

But within the broader health care sector the SPDR S&P Biotech ETF returned a market-beating 43.36% in 2017, nearly double the broader S&P 500.

That's why today we'll show you the three best biotech stocks to buy for 2018.

etfs

Best ETF Performers of the Week (June 19-23, 2017)

June 26, 2017 by Stephen Mack

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Here's a look at the best ETF performers for the week of June 19-23, 2017.

Biotech dominated the list, with four of the top 10 performers.

Inverse energy funds and gold mining ETFs rounded out the list.

Latest News

September 15, 2023 • By Shah Gilani

We're Headed for a Second Banking Crisis - Here's What to Do

September 14, 2023 • By Tom Gentile

Tulips Are the Secret to Trading the Next 300% Rally in AI

September 14, 2023 • By Chris Johnson

Tulips Are Telling Me How To Trade the Next 300% rally in AI
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Penny Hawk Midday Momentum
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Quantum Data Profits Flashpoint Trader Darknet Alpha Accelerators Brutus Alerts Resource Traders Alliance L.A.U.N.C.H. Investor Rob Roy Trader Long-Term Equity Profits

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information